Teratogenic studies on mice with an antiphlogistic substance, 5-(2-diethyl-aminoethyl)-3-phenyl-1,2,4-oxadiazole citrate (1).
D000014:Abnormalities, Drug-Induced; D000818:Animals; D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents; D005314:Embryonic and Fetal Development; D005260:Female; D005333:Fetus / Q000002:abnormalities* / Q000187:drug effects; D005865:Gestational Age; D051379:Mice; D010069:Oxadiazoles; D011247:Pregnancy; D012272:Ribs / Q000002:abnormalities; D012863:Skeleton / Q000002:abnormalities
D000893:Anti-Inflammatory Agents; D000996:Antitussive Agents; D010069:Oxadiazoles